Health

In the health sector, regulation never stands still. We help you anticipate change, adapt with confidence, and seize opportunity.

Subscribe to receive our insights.

We know how overwhelming it can be trying to effectively navigate today's regulatory environment and capitalize on opportunities. Our role is to help you thrive through change – removing unnecessary complexity, anticipating what’s next, and unlocking opportunities for growth. Because we have an in-depth understanding of how commercial dynamics and legislative direction intersect, we provide legal solutions that are aligned with business strategy.

We are uniquely positioned to serve providers and suppliers of health care services and products and all other players in the health care sector. We work with them as regulatory lawyers, and also as their strategic advisers, lobbyists, litigators, and dealmakers. From start-ups to multinational enterprises to trade associations, our clients come from every part of the health care sector of the worldwide economy.

One thing that makes us so effective is that our team includes an exceptionally high number of lawyers who are former senior government officials. This means we have insider insight into institutional thinking and decision-making processes at regulatory agencies so that we can better persuade them to take a certain view or course of action. We activate our influence across industries and institutions to give you the edge.

We also collaborate across our firm to provide seamless cross-border regulatory counseling and representation in the United States, the European Union, Asia, Latin America, Australia, and other major markets. By breaking through regulatory silos and working across borders, we deliver practical, business-focused solutions wherever you operate.

The broad array of organizations we represent in the health care sector, and our ability to meet all of their regulatory and other legal needs make us your one-stop resource for anticipating and responding to health care legal issues. We take you beyond compliance – shaping regulation to create opportunity and long-term advantage.

Fraud and Abuse

Government Price Reporting

Health Legislation and Policy

Health Privacy and Cybersecurity

Telehealth Services

Our lawyers regularly assist clients with issues related to the scope of regulation for digital health products, including health IT technology such as electronic health records and hospital information systems, mobile health products such as mobile medical applications and wearable sensors, and the intersection between traditional medical devices and digital health services. We advise on all aspects of regulation involving the FDA, the European Union, and other local, national, and international regulatory entities. We regularly counsel clients regarding strategic plans that not only comply with government regulations, but also achieve their business objectives on the complex process governing related patent information exchanges.

Learn more

We regularly advise pharmaceutical manufacturers and other life sciences companies on a range of issues, including adherence to federal and state anti-kickback and false claims law, and compliance in connection with a variety of sales and marketing programs or arrangements with customers. We’ve been doing so since before most companies had “fraud and abuse” concerns on their radar. As the government has increased its focus on health care, aggressive enforcement actions have followed.

Our government pricing team is the unquestioned industry leader and serves as a trusted advisor to many of the United States’ leading pharma and biotech companies. We assist manufacturers with applying price reporting and compliance requirements under the Medicaid Drug Rebate Program, Medicare Part B, and the 340B drug pricing program to their particular business models and commercial approaches. In cooperation with the health group, our government contracts team supports manufacturers with drug price computation reporting and compliance obligations associated with the VA Federal Supply Schedule and DOD Tricare retail rebate programs.

Lawyers in our Health practice are conversant with existing laws and policies and closely monitor proposed changes that could affect our clients’ businesses. With a practice that includes many former government officials, we can help you construct and implement strategies to better protect your interests. We are often called upon to advocate before government agencies at the cutting edge of new policy development. We also assist with issues ranging from medical research to patient privacy.

Our global health privacy and cybersecurity team, part of the Hogan Lovells Privacy and Cybersecurity practice, advises health care organizations around the world on health data protection and privacy compliance issues. Whether it is preparing for or responding to cyberattacks and data breaches; advising on transactional work; developing policies, procedures, and training; strengthening incident response protocols; or counseling on regulatory compliance; our team has a vast range of experiences to share on health privacy and security issues.

Increasingly, health care services are conducted via telehealth technologies rather than only through face-to-face interactions. Providers, third-party payers, and manufacturers of health technologies need to understand the complex and evolving federal and state legal issues that could arise when services are delivered through telehealth interactions and across state and national borders. Our comprehensive health regulatory practice advises health care providers, payers, telehealth companies, and others in navigating the maze of federal and state rules, and evolving licensure, coverage, and reimbursement policies, that may apply to telehealth devices, services, and providers.

Hear from our clients and industry leaders

Hogan Lovells has deep, substantive experience and access to regulators. The firm is very plugged in to the industry and evolving."

Chambers & Partners, USA Guide, 2025

Hogan's department is distinguished by its exceptional expertise, responsiveness and commitment to understanding clients' needs. The team excels at integrating legal strategy with business objectives."

Chambers & Partners, USA Guide, 2025

Key contacts

Ronald L. Wisor, Jr.

Partner

Ronald L. Wisor, Jr.

Partner

Washington, D.C.

Dr. Jörg Schickert

Partner

Dr. Jörg Schickert

Partner

Munich

Charlotte Damiano

Partner

Charlotte Damiano

Partner

Paris

Meet the Health team

Representative experience

Assisting a major Health IT company in conducting a complete regulatory assessment of all portfolio and pipeline products to determine which products may be subject to regulation and assisting with bringing products into compliance where needed.

Successfully obtaining clearance for standalone software products in the imaging, anesthesia, and remote patient monitoring space.

Assisting pharmaceutical manufacturers in evaluating discount strategies, including value-and outcomes-based contracting strategies, to determine their impact on price points required to be reported to the federal government, namely Average Manufacturer Price (AMP), Best Price (BP), Average Sales Price (ASP), and Nonfederal Average Manufacturer Price (NFAMP), which can impact reimbursement rates, Medicaid rebate liability, and the 340B ceiling price, and to ensure compliance with fraud and abuse laws.

Assisting multiple manufacturers in designing and proposing demonstration projects to CMMI and Administration testing various value-based arrangements involving various types of drugs and biologics and, in the course of doing so, identifying innovative solutions to government price reporting and other concerns attendant to such arrangements.

Counsel various pharmaceutical and biological trade associations and individual manufacturers on a myriad of cutting-edge issues, including those concerning the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, fraud and abuse, and health information privacy.

Provided comprehensive incident response counsel to numerous health services companies and health plans with breaches involving tens of millions of records, including advising on forensic investigation, breach notification, and communications and interactions with consumers and customers. We also handled the investigations by federal and state health and insurance regulators, state attorneys general, and law enforcement.

Serving as primary outside privacy counsel for Fortune 500 pharmaceutical companies regarding a range of data privacy and security matters, including providing advice regarding international data protection, data use agreements, and privacy policies and procedures, as well as performing comprehensive website reviews.

Advising leading digital health companies on data privacy matters with regard to clinical trials in the EU involving both pan-European strategic advice and detailed country-specific guidance.

Awards and recognitions

Band 1 for Healthcare District of Columbia

Chambers USA

2025

Band 2 for Healthcare: The Elite – USA – Nationwide

Chambers USA

2025

Band 1 for Privacy & Data Security: Healthcare – USA – Nationwide

Chambers USA

2025

Tier 1 for Healthcare: Life Sciences

The Legal 500

2025

Tier 2 Healthcare: Health Insurers

Legal 500 USA

2025

Tier 2 Healthcare: Service Providers

Legal 500 USA

2025

Band 3 for Healthcare: Florida

Chambers USA

2025

Band 4 for Healthcare: New York

Chambers USA

2025

Resources

Our thinking

Talking the Cure Podcast

Our team is always thinking about how to foresee and conquer the most significant industry issues facing our clients. In 2020, we launched the podcast "Talking the Cure" where we cover cutting-edge topics such as AI, digital health, diversity in clinical trials, supply chains, the Inflation Reduction Act, and more.

Learn more

Guide

Horizons 2025 Life Sciences and Health Care Edition

Our Horizons edition brings together insights from across our global Life Sciences and Health Care team, exploring the issues and developments shaping the future of the industry.

Learn more

Other ways we can help you

Navigate change with our latest insights

News

FDA extends comment period for real-time clinical trials pilot, AI use in studies (updated)

01 June 2026

Insights and Analysis

Q1/ 2026 - Life Sciences Law Update

04 May 2026

Insights and Analysis

China’s medical insurance enforcement in 2026: New rules, active campaign, and implications for pharmaceutical companies

24 April 2026

News

FDA’s evolving CBD position meets the CMS substance access pilot

24 April 2026

View more insights and analysis

Health

In the health sector, regulation never stands still. We help you anticipate change, adapt with confidence, and seize opportunity.

Explore our capabilities

AI and Digital Health

Fraud and Abuse

Government Price Reporting

Health Legislation and Policy

Health Privacy and Cybersecurity

Telehealth Services

AI and Digital Health

Fraud and Abuse

Government Price Reporting

Health Legislation and Policy

Health Privacy and Cybersecurity

Telehealth Services

Hear from our clients and industry leaders

Hogan Lovells has deep, substantive experience and access to regulators. The firm is very plugged in to the industry and evolving."

Hogan's department is distinguished by its exceptional expertise, responsiveness and commitment to understanding clients' needs. The team excels at integrating legal strategy with business objectives."

Key contacts

Representative experience

Awards and recognitions

Band 1 for Healthcare District of Columbia

Band 2 for Healthcare: The Elite – USA – Nationwide

Band 1 for Privacy & Data Security: Healthcare – USA – Nationwide

Tier 1 for Healthcare: Life Sciences

Tier 2 Healthcare: Health Insurers

Tier 2 Healthcare: Service Providers

Band 3 for Healthcare: Florida

Band 4 for Healthcare: New York

Resources

Other ways we can help you

Life Sciences and Health Care

Technology

Manufacturing and Industrials

Consumer

Global Regulatory

Medical Devices and Technology Regulatory

Pharmaceuticals and Biotechnology Regulatory

Data Privacy and Cybersecurity

Government Contracts

International Trade and Investment

Navigate change with our latest insights

CMS Health Tech Ecosystem moves from vision to deployment

FDA AI tool Elsa 4.0 and HALO unveiled

Regulatory Inflation in the EU Digital Ecosystem

Q1/ 2026 - Life Sciences Law Update

China’s medical insurance enforcement in 2026: New rules, active campaign, and implications for pharmaceutical companies

FDA’s evolving CBD position meets the CMS substance access pilot

You may also be interested in...

ABA’s Antitrust in Healthcare Conference

AI Health Law & Policy Summit 2026

Hogan Lovells reports record results for the third consecutive year, announcing nearly US$3.3 billion in gross revenue for FY2025, consolidating its 6-year drive of sustainable growth

Zurich: Life Sciences and Health Care Horizons 2025

AI Health Law Policy Summit 2025

Hogan Lovells welcomes former HHS official Maura Calsyn to Health practice

Breakfast Seminar Life Sciences: Update regulatory ontwikkelingen in Nederland en de EU

Hogan Lovells rings in 2025 with 28 new partner and 47 new counsel promotions

Hogan Lovells APAC Life Sciences and Health Care Webinar Series - Spotlight on the U.S. - Session 6

CLE

BIO International Convention

AI Health Law & Policy Summit

Hogan Lovells represents Kaiser Foundation Hospitals in its launch of Risant Health and in its acquisition of Geisinger Health

ABA Washington Health Law Summit | AI in Healthcare: Parting the Mist to Get to Reality

PLI's Hot Topics in Health Care Law 2023 Program

ASHP Midyear Conference 2023

Hogan Lovells counsels Meharry and The Diaspora Human Genomics Institute in academic-industry collaboration to promote genomics research equity

Hogan Lovells celebrates as a record eight partners are selected among Law360’s MVPs

Digital Deep Dive

Real Estate Life Sciences: UK outlook

Medicaid and Government Pricing Congress

Biomed Israel: 2023 Regulatory outlook: Medical technology trends shaping the future

The American Bar Association’s 33rd National Institute on Health Care Fraud

Why IP lawyers should care about the IRA

ACI 17th Annual “BIG FOUR” Pharmaceutical Pricing Boot Camp

Health care antitrust leader joins Hogan Lovells in Washington, D.C., strengthening global antitrust capabilities

Healthcare Law and Compliance Institute

Digital health: The key things insurers need to know

Medical Devices Update

Biotech Showcase and exclusive reception during the J.P. Morgan 41st Annual Healthcare Conference

Former Deputy Chief of the Criminal Division, Southern District of New York Kristy Greenberg joins Hogan Lovells' New York office as partner